| Brokerage Reports (Showing 1 to 10 of 12) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
StarMine Author Rating | More Info |
| EPS Accuracy * |
Portfolio Return ** |
| 29-Jan-10 | Collins Stewart LLC | Louise Chen | Use of Savella Increasing, Reiterating Buy | 3 | $10 | | | View Abstract |
| 21-Jan-10 | Thomson StreetEvents | N/A | FRX - Event Transcript of Forest Laboratories, Inc. conference call, Jan. 19, 2010 / 10:00am ET | 21 | $75 | | | View Abstract |
| 21-Jan-10 | Thomson StreetEvents | N/A | FRX - Event Brief of Forest Laboratories, Inc. conference call, Jan. 19, 2010 / 10:00am ET | 23 | $75 | | | View Abstract |
| 21-Jan-10 | Roth Capital Partners, Inc. | Research Department | Morning Call Summary | 12 | $25 | | | View Abstract |
| 20-Jan-10 | Roth Capital Partners, Inc. | Scott R. Henry CFA, Andrew Vaino PhD | Public Citizen highlights "known" risks with Savella | 5 | $10 | | | View Abstract |
| 20-Jan-10 | Collins Stewart LLC | Louise Chen | February 2010 Catalyst Calendar | 25 | $75 | | | View Abstract |
| 19-Jan-10 | Collins Stewart LLC | Louise Chen | Quality F3Q10, FRX Poised to Beat F2010 Guidance | 13 | $50 | | | View Abstract |
| 13-Jan-10 | Thomson StreetEvents | N/A | FRX - Event Transcript of Forest Laboratories, Inc. conference call, Jan. 13, 2010 / 11:00am ET | 7 | $75 | | | View Abstract |
| 11-Jan-10 | Collins Stewart LLC | Louise Chen | FDA AC Meeting on Bystolic Non Event For FRX; Reiterating Buy | 3 | $10 | | | View Abstract |
| 9-Jan-10 | Thomson StreetEvents | N/A | FRX - Event Transcript of Forest Laboratories, Inc. conference call, Jan. 07, 2010 / 8:30am ET | 47 | $75 | | | View Abstract |